[1] Bohn A, Khodaee M, Schwenk T (2003) Ephedrine and Other Stimulants As Ergogenic Aids. Current Sports Medicine Reports 2:220–225.
[2] Bennett S, Hoffman N, Monga M (2004) Ephedrine- and Guaifenesin-Induced Nephrolithiasis. The journal of Alternative and Complementary Medicine 10(6):967-969.
[3] Ephedra sinica plants. Disponível em http://www.cactusplaza.com/ephedra-sinica-plants (acedido em 15-05-2013).
[4] Ephedrine ban. Disponível em http://toxipedia.org/display/toxipedia/Ephedrine+Ban (acedido em 15-05-2013).
[5] Ephedra. Disponível em http://ephedra.co.uk/ (acedido em 15-05-2013).
[6] Palamar J (2011) How ephedrine escaped regulation in the United States: A historical review of misuse and associated policy. Health Policy 99:1–9.
[7] Lee M (2011) The history of Ephedra (ma-huang) The Journal Of The Royal College Of Physicians Of Edinburgh 41 (1): 78-84.
[8] Diego Maradona. Disponível em https://pt.wikipedia.org/wiki/Diego_Maradona (acedido em 15-05-2013).
[9] Why Ephedra Was Banned?. Disponível em http://www.ecastack-pills.com/why-ephedra-was-banned/ (acedido em 15-05-2013).
[10]Ephedrine. Disponível em http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=160964651&viewopt=PubChem (acedido em 17-05-2013)
[11]  Ma G, et al. (2007) Pharmacological Effects of Ephedrine Alkaloids on Human α1- and β2-Adrenergic Receptor Subtypes. The Journal of Pharmacology and Experimental Therapeutics, Vol. 322, No. 1
[12] Ephedrine. Disponível em: http://www.chemspider.com/Chemical-Structure.8935 (acedido 17-05-2013)
[13]Ephedrine. Disponível em http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/PhysicalProperties.jsp?calledFrom=lite (acedido em 17-05-2013)
[14] Ephedrine. Disponível em: http://www.drugbank.ca/drugs/DB01364 (acedido em 17-05-2013)
[15] Csajka C, Haller C, Benowitz N, Verotta D (2005) Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects. British Journal of Clinical Pharmacology 59(3): 335–345.
[16](L)-EPHEDRINE CASRN: 299-42-3. Disponível em: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+299-42-3. (acedido em 20-05-2013)
[17] Ephedrine. Disponível em http://www.inchem.org/documents/pims/pharm/pim209.htm#SectionTitle:1.1 Substance (acedido em 17-05-2013)
[18] Kobayashi S, et al. (2003) The Sympathomimetic Actions of l-Ephedrine and d-Pseudoephedrine: Direct Receptor Activation or Norepinephrine Release?. Anesth Analg, 97:1239–45
[19] Huizinga M (2007) Weight-Loss Pharmacotherapy: A Brief Review. CliniCal Diabetes 25(4):135-140.
[20] Jia J, Zeng X, Li Y, Ma S, Bai J (2013) Ephedrine induced thioredoxin-1 expression through β-adrenergic receptor/cyclic AMP/protein kinase A/dopamine- and cyclic AMP-regulated phosphoprotein signaling pathway Cellular Signalling 25:1194–1201.
[21]Folheto informative efedrina Labesfal. Disponível em http://www.infarmed.pt/infomed/download_ficheiro.php?med_id=37476&tipo_doc=fi (acedido em 18-05-2013)
[22]Hipotensão arterial. Disponível em http://saude.sapo.pt/saude-medicina/medicacao-doencas/doencas/hipotensao-arterial.html (acedido em 18-05-2013)
[23] Sistema respiratório. Disponível em http://aloevera.saludisima.com/sistema-respiratorio/ (acedido em 18-05-2013)
[24] Efedrina. Disponível em http://www.inchem.org/documents/pims/pharm/pim209.htm#SectionTitle:2.2  Summary of clinical effects (acedido em 18-05-2013)
[25] Magkos F, Kavouras S (2004) Caffeine and Ephedrine: Physiological, Metabolic and Performance-Enhancing Effects. Sports Medicine 34 (13): 871-889.
[26] Ricaurte G, McCann U (2005) Recognition and management of complications of new recreational drug use. Lancet 365:2137–45.
[27] Ephedrine. Disponível em http://toxnet.nlm.nih.gov/ (acedido em 20-05-2013)
[28] Safety first. DIsponível em https://sp.cege.ucl.ac.uk/Picture%20Library/Forms/DispForm.aspx?ID=18 (acedido em 20-05-2013)
[29] Samenuk D (2002) Adverse Cardiovascular Events Temporally Associated With Ma Huang, an Herbal Source of Ephedrine. Mayo Clinic Proceedings 77:12-16.
[30] Olson K (2007) Poisoning & Drug Overdose. Lange Medical Books/McGraw-Hill. New York.
[31] Dunnick J, Kissling G, Gerken D, Vallant M, Nyska A (2007) Cardiotoxicity of Ma Huang/Caffeine or Ephedrine/Caffeine in a Rodent Model System. Toxicologic Pathology 35:657–664.
[32] Brown J, Yamamoto B (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacology & Therapeutics 99 (1) :45-53.
[33] Rossato L. (2009) Seminário- A sinefrina e o seu potencial cardiotóxico: o uso no emagrecimento e metodologias analíticas para detectar a sinefrina. Porto.
[34] Fat New World. Disponível emhttp://www.fat-new-world.com/2012/11/curso-de-nutricao-no-exercicio-fisico-e.html (Acedido 21-05-2013)

[35] Nutrição. Disponível emhttp://web.taktos.com.br/new/index.php?option=com_content&view=article&id=83:doping-no-esporte&catid=45:nutricao&Itemid=78(Acedido 21-05-2013)

[36] Substances and Methods Prohibited In-Competition. Disponível emhttp://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/The-2011-Prohibited-List/Prohibited-In-Competition/ (Acedido 21-05-2013)

[37] Ephedrine. Disponível emhttp://en.wikipedia.org/wiki/Ephedrine (Acedido 21-05-2013)

[38] Methamphetamine . Disponível em http://en.wikipedia.org/wiki/Methamphetamine (Acedido 21-05-2013)